Tuesday May 11, 2:00 pm Eastern Time
Company Press Release
SOURCE: Bradley Pharmaceuticals, Inc.
Bradley Pharmaceuticals Accelerates Field
Force Expansion
FAIRFIELD, N.J., May 11 /PRNewswire/ -- Bradley Pharmaceuticals, Inc. (Nasdaq: BPRX - news) today
announced it has authorized an expansion of up to 120 field representatives which includes 60 sales people
and 60 sample distributors who work in conjunction with the field sales people. The increase of its specialty
pharmaceutical selling effort is in response to growing sales successes in some key markets.
This expansion authorization accelerates a previous plan to enlarge the field force to 100 sales field
representatives by the end of the year. This larger sales force staff will be supported by improved sales training
programs coupled with more advanced performance monitoring tools.
Bradley Pharmaceuticals, Inc. Chairman & CEO, Daniel Glassman, stated, ''Increasing our presence among
the nation's most productive physicians remains a cornerstone to successfully implementing our strategy of
Acquire, Enhance and Grow. This expansion, currently from a base force of 80, is encouraged by the success
in net market share growth of some of our key brands. This expansion also may further validate Bradley as a
partner of choice for co-marketing and acquisition agreements in selected markets with leading biotech and
pharmaceutical companies. We expect this increase in sales presence to increase SG&A to levels that are
commensurate with sales growth and the redeployment of our assets from the closing of our manufacturing
operations and the outsourcing of all our products.''
Bradley Pharmaceuticals, Inc. markets brandname products and over-the-counter pharmaceuticals and
health-related products throughout the United States as well as in 27 international markets. Bradley Common A
Shares (BPRX) are traded on the Nasdaq National Market System.
Please visit the Bradley Pharmaceuticals' website at bradpharm.com.
This release may contain forward-looking statements that reflect management's current views of future events
and operations. These forward-looking statements are based on assumptions and external factors, including
assumptions relating to regulatory action, capital requirements and competing products. Any changes in such
assumptions are external factors and could produce significantly different results.
SOURCE: Bradley Pharmaceuticals, Inc.
More Quotes and News:
Bradley Pharmaceuticals Inc (Nasdaq:BPRX - news)
Related News Categories: biotech, medical/pharmaceutical
|
